Considerable changes have occurred in the management of differentiated thyroid cancer
(DTC) during the past four decades, based on improved knowledge of the biology of DTC …

Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the American Thyroid Association's …

This ESMO Clinical Practice Guideline provides updated state-of-the-art recommendations
on management of thyroid cancer (diagnosis, treatment and follow-up), compiled by a …

Background It is not known whether low-dose radioiodine (1.1 GBq [30 mCi]) is as effective
as high-dose radioiodine (3.7 GBq [100 mCi]) for treating patients with differentiated thyroid …

Background It is not clear whether the administration of radioiodine provides any benefit to
patients with low-risk thyroid cancer after a complete surgical resection. The administration …

Background Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Methods Six scientific Italian societies entitled to …

Cervical ultrasound scanning (US) is considered a key examination, by all major thyroid and
endocrine specialist societies for the postoperative follow-up of thyroid cancer patients to …

Thyroid cancer is the most common of the endocrine malignancies and it represents< 1% of
all human tumors. The annual incidence of thyroid cancer varies considerably by …

Context: The current use of life-long follow-up in patients with papillary thyroid cancer (PTC)
is based largely on the study of individuals diagnosed and treated in the latter half of the …

Background: Radioiodine remnant ablation (RRA) has traditionally been one of the
cornerstones of differentiated thyroid cancer (DTC) treatment. The decision to use RRA in …